Should I obtain a nasal swab to test for MRSA colonization?

Should You Obtain a Nasal Swab for MRSA Colonization?

No, you should not routinely obtain a nasal swab to test for MRSA colonization in a patient who simply suspects they have MRSA without specific clinical indications. MRSA nasal screening is a targeted tool with specific evidence-based applications, not a general screening test for worried patients.

When MRSA Nasal Screening IS Indicated

The evidence strongly supports MRSA nasal screening in these specific clinical scenarios:

Pre-operative Screening (Strongest Evidence)

• Cardiac surgery patients - MRSA colonization increases surgical site infection risk 9-fold 1
• Orthopedic surgery patients - MSSA colonization increases infection risk 3- to 6-fold 1, 2
• Screening should be performed according to local epidemiology and institutional resources 2
• If positive: Treat with intranasal mupirocin 2% twice daily for 5 days before surgery 1, 2

Active Infection Management (Antimicrobial Stewardship)

MRSA nasal screening has excellent utility for ruling out MRSA infection when empiric antibiotics are being considered:

• Pneumonia: Negative predictive value of 97.8-99.2% 3, 4
• Bacteremia: Negative predictive value of 97.9% 3
• Skin/soft tissue infections: Negative predictive value of 92.0-99.4% 3, 5, 6
• Urinary tract infections: Negative predictive value of 100% 3

Key point: A negative MRSA nasal swab allows safe de-escalation of anti-MRSA antibiotics, reducing unnecessary vancomycin exposure 7, 3, 4

Recurrent Skin Infections (Limited Role)

According to IDSA guidelines, screening may be considered only when 8:

• Patient has ≥2 discrete SSTI episodes at different sites over 6 months
• Infections persist despite optimized hygiene measures
• Ongoing transmission is occurring among household contacts

However: Even in this scenario, screening cultures prior to decolonization are not routinely recommended if at least one prior infection was documented as MRSA 8

When MRSA Nasal Screening Is NOT Indicated

Do not screen in these situations:

• Patient concern or anxiety about MRSA without active infection
• Single episode of skin infection
• Cellulitis (non-purulent infection) - unless specific risk factors present 9
• Routine screening of asymptomatic individuals in community settings

Important Caveats

The Positive Predictive Value Problem

While negative MRSA nasal swabs are highly reliable, positive swabs do not confirm active MRSA infection:

• Positive predictive value for MRSA pneumonia: only 35.4% 4
• Positive predictive value for MRSA SSTI: 70% 5
• 12-30% of the general population carries MRSA nasally without infection 1, 10, 1

Colonization ≠ Infection

A positive nasal swab indicates colonization, not disease. The patient may be colonized but have an infection from a different organism, or no infection at all.

Resistance Concerns

Universal screening and decolonization without clear indication may promote mupirocin resistance 8, 2. One study showed mupirocin decreased nasal colonization but did not reduce first-time SSTI incidence 8.

What to Do Instead for Your Patient

Since your patient "thinks they have MRSA" without documented infection:

1. Assess for actual infection: Look for purulent drainage, abscess, cellulitis with specific risk factors (penetrating trauma, injection drug use, prior MRSA infection) 9

2. If active purulent infection present:

   • Incision and drainage is primary treatment 9
   • Culture the wound directly (not the nose)
   • Consider empiric anti-MRSA antibiotics based on local resistance patterns

3. If recurrent infections:

   • First optimize hygiene: cover wounds, avoid sharing personal items, clean high-touch surfaces 8
   • Only consider decolonization if infections persist despite hygiene measures 8

4. If no active infection: Reassure the patient and educate about proper wound care and hygiene measures

Bottom line: MRSA nasal screening is a precision tool for specific clinical scenarios (pre-operative assessment, antimicrobial stewardship in active infections), not a general screening test for patient reassurance.